North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 11 of 11
Details
UPD
sitematrix Changed from 0 to
20/11/2023 12:41:31
(DavidS )
UPD
FurtherInformation Changed from
Approved for treating anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer (NSCLC) in adults who have already had crizotinib in line with NICE.
Approved
20/11/2023 12:41:31
(DavidS )
UPD
Brigatinib (Alunbrig
®
) updated
20/11/2023 12:41:31
(DavidS )
UPD
Published from Draft Mode
20/05/2021 13:15:58
(LoweryM )
UPD
Brigatinib (Alunbrig
®
) updated
20/05/2021 13:15:30
(LoweryM )
UPD
Brigatinib (Alunbrig
®
) updated
19/05/2021 16:04:01
(DavidS )
LDL
Link Added : NICE TA670: Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor : https://www.nice.org.uk/guidance/ta670
19/05/2021 16:03:48
(DavidS )
UPD
Brigatinib (Alunbrig
®
) NICE TA670
19/05/2021 16:03:13
(DavidS )
UPD
Brigatinib Published from Draft Mode
30/05/2019 15:39:50
(DavidS )
LDL
Link Added : NICE TA571: Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib : https://www.nice.org.uk/guidance/ta571
25/04/2019 16:14:35
(DavidS )
ADD
Brigatinib (Alunbrig
®
) NICE TA571
25/04/2019 16:14:03
(DavidS )